131 related articles for article (PubMed ID: 22961594)
21. Endothelial S1P
Nitzsche A; Poittevin M; Benarab A; Bonnin P; Faraco G; Uchida H; Favre J; Garcia-Bonilla L; Garcia MCL; Léger PL; Thérond P; Mathivet T; Autret G; Baudrie V; Couty L; Kono M; Chevallier A; Niazi H; Tharaux PL; Chun J; Schwab SR; Eichmann A; Tavitian B; Proia RL; Charriaut-Marlangue C; Sanchez T; Kubis N; Henrion D; Iadecola C; Hla T; Camerer E
Circ Res; 2021 Feb; 128(3):363-382. PubMed ID: 33301355
[TBL] [Abstract][Full Text] [Related]
22. Sphingolipids in the Heart: From Cradle to Grave.
Kovilakath A; Jamil M; Cowart LA
Front Endocrinol (Lausanne); 2020; 11():652. PubMed ID: 33042014
[TBL] [Abstract][Full Text] [Related]
23. Sphingolipid Mediators of Myocardial Pathology.
Kovilakath A; Cowart LA
J Lipid Atheroscler; 2020 Jan; 9(1):23-49. PubMed ID: 32821720
[TBL] [Abstract][Full Text] [Related]
24. Identification of Novel miRNAs Involved in Cardiac Repair Following Infarction in Fetal and Adolescent Sheep Hearts.
Lock MC; Tellam RL; Darby JRT; Soo JY; Brooks DA; Seed M; Selvanayagam JB; Morrison JL
Front Physiol; 2020; 11():614. PubMed ID: 32587529
[TBL] [Abstract][Full Text] [Related]
25. Metabolic Disturbances Identified in Plasma Samples from ST-Segment Elevation Myocardial Infarction Patients.
Goulart VAM; Santos AK; Sandrim VC; Batista JM; Pinto MCX; Cameron LC; Resende RR
Dis Markers; 2019; 2019():7676189. PubMed ID: 31354891
[TBL] [Abstract][Full Text] [Related]
26. The role of dihydrosphingolipids in disease.
Magaye RR; Savira F; Hua Y; Kelly DJ; Reid C; Flynn B; Liew D; Wang BH
Cell Mol Life Sci; 2019 Mar; 76(6):1107-1134. PubMed ID: 30523364
[TBL] [Abstract][Full Text] [Related]
27. Percutaneous Closure of Left Atrial Appendage significantly affects Lipidome Metabolism.
Yücel G; Behnes M; Barth C; Wenke A; Sartorius B; Mashayekhi K; Yazdani B; Bertsch T; Rusnak J; Saleh A; Hoffmann U; Fastner C; Lang S; Zhou X; Sattler K; Borggrefe M; Akin I
Sci Rep; 2018 Apr; 8(1):5894. PubMed ID: 29650978
[TBL] [Abstract][Full Text] [Related]
28. Sphingolipid regulators of cellular dysfunction in Type 2 diabetes mellitus: a systems overview.
Ross JS; Russo SB; Chavis GC; Cowart LA
Clin Lipidol; 2014; 9(5):553-569. PubMed ID: 29643939
[TBL] [Abstract][Full Text] [Related]
29. Integrated Metabolomics and Network Pharmacology Approach to Explain Possible Action Mechanisms of Xin-Sheng-Hua Granule for Treating Anemia.
Pang HQ; Yue SJ; Tang YP; Chen YY; Tan YJ; Cao YJ; Shi XQ; Zhou GS; Kang A; Huang SL; Shi YJ; Sun J; Tang ZS; Duan JA
Front Pharmacol; 2018; 9():165. PubMed ID: 29551975
[TBL] [Abstract][Full Text] [Related]
30. Sphingolipids and Lipoproteins in Health and Metabolic Disorders.
Iqbal J; Walsh MT; Hammad SM; Hussain MM
Trends Endocrinol Metab; 2017 Jul; 28(7):506-518. PubMed ID: 28462811
[TBL] [Abstract][Full Text] [Related]
31. QGQS Granule in SHR Serum Metabonomics Study Based on Tools of UPLC-Q-TOF and Renin-Angiotensin-Aldosterone System Form Protein Profilin-1.
Li K; Li C; Wang J; Cui H; Dong Y; Liu R; Hu Y
Evid Based Complement Alternat Med; 2017; 2017():4854720. PubMed ID: 28367224
[TBL] [Abstract][Full Text] [Related]
32. Platelet and Erythrocyte Sources of S1P Are Redundant for Vascular Development and Homeostasis, but Both Rendered Essential After Plasma S1P Depletion in Anaphylactic Shock.
Gazit SL; Mariko B; Thérond P; Decouture B; Xiong Y; Couty L; Bonnin P; Baudrie V; Le Gall SM; Dizier B; Zoghdani N; Ransinan J; Hamilton JR; Gaussem P; Tharaux PL; Chun J; Coughlin SR; Bachelot-Loza C; Hla T; Ho-Tin-Noé B; Camerer E
Circ Res; 2016 Sep; 119(8):e110-26. PubMed ID: 27582371
[TBL] [Abstract][Full Text] [Related]
33. Sphingolipid De Novo Biosynthesis: A Rheostat of Cardiovascular Homeostasis.
Sasset L; Zhang Y; Dunn TM; Di Lorenzo A
Trends Endocrinol Metab; 2016 Nov; 27(11):807-819. PubMed ID: 27562337
[TBL] [Abstract][Full Text] [Related]
34. Implication of sphingosin-1-phosphate in cardiovascular regulation.
Li N; Zhang F
Front Biosci (Landmark Ed); 2016 Jun; 21(7):1296-313. PubMed ID: 27100508
[TBL] [Abstract][Full Text] [Related]
35. Effect of Fingolimod on Platelet Count Among Multiple Sclerosis Patients.
Farrokhi M; Beni AA; Etemadifar M; Rezaei A; Rivard L; Zadeh AR; Sedaghat N; Ghadimi M
Int J Prev Med; 2015; 6():125. PubMed ID: 26900439
[TBL] [Abstract][Full Text] [Related]
36. TIMP3 interplays with apelin to regulate cardiovascular metabolism in hypercholesterolemic mice.
Stöhr R; Kappel BA; Carnevale D; Cavalera M; Mavilio M; Arisi I; Fardella V; Cifelli G; Casagrande V; Rizza S; Cattaneo A; Mauriello A; Menghini R; Lembo G; Federici M
Mol Metab; 2015 Oct; 4(10):741-52. PubMed ID: 26500845
[TBL] [Abstract][Full Text] [Related]
37. Gene Expression Profiles Link Respiratory Viral Infection, Platelet Response to Aspirin, and Acute Myocardial Infarction.
Rose JJ; Voora D; Cyr DD; Lucas JE; Zaas AK; Woods CW; Newby LK; Kraus WE; Ginsburg GS
PLoS One; 2015; 10(7):e0132259. PubMed ID: 26193668
[TBL] [Abstract][Full Text] [Related]
38. Sphingolipids in cardiovascular diseases and metabolic disorders.
Borodzicz S; Czarzasta K; Kuch M; Cudnoch-Jedrzejewska A
Lipids Health Dis; 2015 Jun; 14():55. PubMed ID: 26076974
[TBL] [Abstract][Full Text] [Related]
39. Maternal plasma and amniotic fluid sphingolipids profiling in fetal Down syndrome.
Charkiewicz K; Blachnio-Zabielska A; Zbucka-Kretowska M; Wolczynski S; Laudanski P
PLoS One; 2015; 10(5):e0127732. PubMed ID: 26000716
[TBL] [Abstract][Full Text] [Related]
40. Diaphragm dysfunction in heart failure is accompanied by increases in neutral sphingomyelinase activity and ceramide content.
Empinado HM; Deevska GM; Nikolova-Karakashian M; Yoo JK; Christou DD; Ferreira LF
Eur J Heart Fail; 2014 May; 16(5):519-25. PubMed ID: 24596158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
